|Bid||326.00 x 800|
|Ask||326.49 x 2200|
|Day's range||317.18 - 335.75|
|52-week range||65.49 - 497.49|
|Beta (5Y monthly)||1.49|
|PE ratio (TTM)||218.86|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
CAMBRIDGE, Mass., October 21, 2021--U.S. CDC Advisory Committee on Immunization Practices Recommends Booster Vaccination with Moderna’s COVID-19 Vaccine
CAMBRIDGE, Mass., October 20, 2021--Moderna Announces FDA Authorization of a Booster Dose of Moderna’s COVID-19 Vaccine in the U.S.
CAMBRIDGE, Mass., October 14, 2021--Moderna announces FDA Advisory committee unanimously votes in support of emergency use for a booster dose of Moderna’s COVID-19 vaccine in the U.S.